MedPath

Absci Corp

🇺🇸United States
Ownership
-
Employees
156
Market Cap
$509.8M
Website
Introduction

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

© Copyright 2025. All Rights Reserved by MedPath